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Sir,
The need for broad and accessible testing coverage has been recognised as one of the key
elements to control the coronavirus disease 2019 (Covid-19) pandemic. The reverse
transcriptase-polymerase chain reaction (RT-PCR) technique has been the gold standard for
the diagnosis of Covid-19. However, it also represents a bottleneck for broadening testing pol-
icies, particularly in low-resource settings, because it depends on specialised laboratories,
requires trained personnel and has relatively high turn-around times. In this regard, Chow
et al. [1] proposed the pooling strategy to increase mass screening capacity, which is particu-
larly necessary in low-income countries. Herein, we aim to present the importance of evalu-
ating RT-PCR-sparing strategies to overcome testing shortages by deploying available
point-of-care (PoC) tests.
In countries such as Brazil, RT-PCR testing for patients reliant on the public health system
is concentrated in a few public laboratories and a network of additional support laboratories
requisitioned in response to the ongoing crisis. Given the enormous demand for testing, results
are often reported 1 week after sample collection or even later. This delay hinders adherence to
self-isolation practices and the implementation of public-health measures to avoid transmis-
sion to close contacts [2].
Recently, PoC tests based on either viral antigen or RNA detection have been developed and
evaluated, showing high specificity and sensitivity (although the latter has been more variable) [3–
8]. Nonetheless, the sensitivity of these tests increases as Ct values decrease, (indicating higher
viral loads), which is the situation most often seen in symptomatic patients. Additionally, these
tests usually have a lower cost than RT-PCR, are easy to use and are scalable [4–8].
We consider that widespread use of available PoC tests (Fig. 1) should be urgently evaluated
as an RT-PCR sparing strategy, with potential individual and public-health benefits, particu-
larly in settings with high RT-PCR positivity rates. The benefits include possibility of diagnosis
on initial presentation, which may facilitate adherence to self-isolation; faster notification of
close contacts, allowing more easy and effective tracing; and, as patients receive appropriate
medical guidance in a single visit, prevention of unnecessary mobility of symptomatic patients.
Furthermore, public-health laboratories would face a lower demand for RT-PCR processing,
which would likely decrease turnaround time. The disadvantage is the need for two swab col-
lections at the same visit in patients with negative PoC tests.
The use of PoC tests for detection of severe acute respiratory syndrome-coronavirus-2
(SARS-CoV-2) in symptomatic patients before RT-PCR may be a valuable strategy to
Fig. 1. Proposed diagnostic algorithm for symptomatic patients with suspected Covid-19 using an RT-PCR-sparing strategy
based on point-of-care testing.
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overcome limited RT-PCR availability and mitigate its conse-
quences. Studies modelling such strategies and assessing their
implementation are urgently needed.
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